Heim600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Við síðustu lokun
3,72 ¥
Dagbil
3,67 ¥ - 3,75 ¥
Árabil
3,06 ¥ - 4,97 ¥
Markaðsvirði
9,17 ma. CNY
Meðalmagn
41,59 m.
V/H-hlutf.
20,86
A/V-hlutfall
-
Aðalkauphöll
SHA
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 3,90 ma. | -5,29% |
Rekstrarkostnaður | 838,57 m. | 2,13% |
Nettótekjur | 68,89 m. | -58,22% |
Hagnaðarhlutfall | 1,77 | -55,86% |
Hagnaður á hvern hlut | — | — |
EBITDA | 166,37 m. | -50,19% |
Virkt skatthlutfall | 34,67% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 2,74 ma. | -12,32% |
Heildareignir | 14,08 ma. | -1,31% |
Heildarskuldir | 7,67 ma. | -7,75% |
Eigið fé alls | 6,41 ma. | — |
Útistandandi hlutabréf | 2,52 ma. | — |
Eiginfjárgengi | 1,65 | — |
Arðsemi eigna | 2,00% | — |
Ávöxtun eigin fjár | 3,67% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 68,89 m. | -58,22% |
Handbært fé frá rekstri | -192,48 m. | -283,26% |
Reiðufé frá fjárfestingum | -54,77 m. | -55,00% |
Reiðufé frá fjármögnun | -88,11 m. | 49,20% |
Breyting á handbæru fé | -334,93 m. | -222,01% |
Frjálst peningaflæði | -402,50 m. | -471,06% |
Um
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Stofnsett
1988
Vefsvæði
Starfsfólk
10.180
